Patent details

91029 Product Name: PEGASYS et ses dérivés pharmaceutiquement acceptables.

Basic Information

Publication number:
91029
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP971082615
Legal Status:
Expired
Application number:
91029
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/02/221/001 à 008
Marketing Authorization Type:
Marketing Authorization Date:
20/06/2002
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
25/06/2003
First Marketing Authorization date:
20/06/2002
Grant date:
23/01/2004
Activation date:
22/05/2017
Publication date:
23/01/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
20/06/2017
SPC Extension Expiration:
20/06/2017
Rejection date:
Withdrawal date:

Owner

From:
25/06/2003
 
 

Name:
F. HOFFMANN-LA ROCHE AG
Address:
GRENZACHERSTRASSE 124, 4002, BALE, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
25/06/2003
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PALLERONI ALICIA VALLEJO
Address:
United States (US)

2

Name:
BAILON PASCAL SEBASTIAN
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC3
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
04/04/2017
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages